Total Reports
10
FDA CVM filings
Adverse-event records for Wagyu (Cattle) from the FDA Center for Veterinary Medicine.
Data updated June 2026
The record at a glance
Wagyu's FDA record: #438 most-reported cattle breed, 10 total reports, 70.0% death-coded (7 reports).
Read report counts next to breed popularity: a bigger number often just means more owners and more vet visits.
Total Reports
10
FDA CVM filings
Deaths Reported
7
of 10 reports
Death Rate
70.0%
death-coded share
Avg Age at Report
0.2 yr
122.0 kg avg weight
70.0% of 10 wagyu reports involved a death outcome.
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
| Year | Reports | Trend |
|---|---|---|
| 2022 | 1 | |
| 2023 | 8 | |
| 2024 | 1 | |
Wagyu accounts for 10 FDA adverse event reports, ranking #438 by volume among cattle breeds, with 7 reports (70.0%) coded as a death outcome. Mean age at report: 0.2 years, average weight 122.0 kg (269.0 lbs).
Top reported signs: Death (7), Lack of efficacy - NOS (5), Diarrhoea (4). Most-referenced drug: Tulathromycin (7 reports), followed by Ceftiofur Crystalline Free Acid (2) and Florfenicol Inj Sol 30% W Pg (2).
Outcome coding on 10 status-recorded reports is dominated by Died (70.0%). Annual submissions ranged 2,022-2,024 across 3 years on file.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how death rate and rankings are computed.
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.